Hillsdale Investment Management Inc. Deciphera Pharmaceuticals, Inc. Transaction History

Hillsdale Investment Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$12.46 - $15.48 $2,242 - $2,786	-180 Reduced 31.03%	400 $5,000
Q2 2023 Aug 11, 2023	SELL	$13.28 - $15.96 $3.35 Million - $4.03 Million	-252,620 Reduced 99.77%	580 $8,000
Q1 2023 May 10, 2023	SELL	$14.26 - $22.1 $1.07 Million - $1.66 Million	-75,000 Reduced 22.85%	253,200 $3.91 Million
Q4 2022 Feb 13, 2023	BUY	$14.85 - $19.04 $41,580 - $53,312	2,800 Added 0.86%	328,200 $5.38 Million
Q3 2022 Nov 10, 2022	BUY	$12.38 - $20.23 $4.03 Million - $6.58 Million	325,400 New	325,400 $6.02 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.